Expert Interviews

Samantha Olson, MPH, explains the important role of a strong recommendation for maternal influenza vaccination.

Deborah Persaud, MD, details results from her study that aimed to reduce HIV reservoirs in neonates with very early antiretroviral therapy.

Samantha Olson, MPH, breaks down a study highlighting the effectiveness of maternal influenza vaccination and its respective association with influenza-related hospitalizations in infants.

Deborah Persaud, MD, discusses the background and lead-up to her study examining very early ART in neonates born with HIV-1 and if this treatment could be a step towards ART-free treatment.

Todd Wolynn, MD, stresses the need for effective communication within the pediatric physician community to combat misinformation, particularly about influenza vaccination.

An expert pediatrician reviews vaccine coverage rates within the pediatric population, and addresses parents’ and guardians concerns when it comes to vaccinating children against influenza.

In this Contemporary Pediatrics interview, Ari Brown, MD, FAAP, details the benefits of goat milk-based infant formula, discusses FDA authorized Kabrita goat milk-based infant formula, and highlights misconceptions associated with goat milk-based formula.

In this Contemporary Pediatrics interview, Steven Selbst, MD, talks about how preventable unintentional firearm injuries in children can be, as he references an uptick in these cases in his emergency department.

Todd Wolynn, MD, continues the discussion on egg-based vs cell-based influenza vaccines in pediatric populations, commenting on the limitations and concerns with traditional egg-based formulations.

Todd Wolynn, MD, reviews influenza vaccination recommendations for pediatric populations, highlighting the egg-based and cell-based formulations.

An expert pediatrician discusses the complications that arise from pediatric influenza, such as pneumonia and exacerbation of chronic illness.

Todd Wolynn, MD, talks about the spread of influenza among children and their communities.

In the final installment of our RSV Roundtable video series, our panel breaks down the importance of discussing new immunizations with patients now, and how crucial they will be in future RSV seasons.

A discussion of the intense 2023 RSV season, approved treatment tools, and an outlook for 2024.

In the fourth installment of RSV Roundtable, our panel explains the challenges in protecting the senior population against RSV.

Candice Jones, MD, shares what she wants to continue into the new year when it comes to pediatric health care.

Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses vaccine hesitancy and hopes to increase vaccination for preventable diseases in 2024.

In the third installment of RSV Roundtable, our panel discusses the impact nirsevimab has had this RSV season.

William Gallentine, DO, explains the initial signs of pediatric seizures and epilepsy and how pediatricians can point them out, all while reassuring parents and determining proper care.

Gary Marshall, MD, discusses the safety and efficacy of cell based influenza vaccines and some of the knowledge gaps that remain about influenza virus in children.

An expert explains the differences between egg-based and cell-based influenza vaccines.

An expert describes the current pediatric recommendations for influenza vaccinations as well as factors that contribute to the effectiveness of the vaccine.

Gary Marshall, MD, discusses the critical role that children play in influenza transmission.

Gary Marshall, MD, provides an overview of influenza and the timing and duration of the disease from recent flu seasons.

In this Contemporary Pediatrics interview, Lawrence Eichenfield, MD, explains additional challenges pediatric atopic dermatitis patients face during winter months and colder weather.

Lawrence Eichenfield, MD, reacts to the FDA's acceptance of a supplemental New Drug Application for roflumilast cream 0.15% to treat atopic dermatitis (AD) in patients aged 6 years and older.

Ravi Jhaveri, MD, shares approaches to addressing common concerns among parents and guardians regarding the flu vaccine for children.

Ravi Jhaveri, MD, discusses challenges in patient access to flu vaccines, and comments on the need to increase opportunities for vaccination for all pediatric patients.

Ravi Jhaveri, MD, reviews the different types of influenza vaccines for pediatric populations, highlighting the differences between egg-based and cell-based flu vaccines.

Ravi Jhaveri, MD, comments on the burden of influenza on children, specifically secondary infections and post-flu fatigue.